Echocardiographic Assessment of Cardiac Valvular Regurgitation With Lorcaserin From Analysis of 3 Phase 3 Clinical Trials-Reference-Cited by-同舟云学术

Echocardiographic Assessment of Cardiac Valvular Regurgitation With Lorcaserin From Analysis of 3 Phase 3 Clinical Trials

Published:2013-07 Issue:4 Volume:6 Page:560-567
ISSN:1941-9651
Container-title:Circulation: Cardiovascular Imaging
language:en
Short-container-title:Circ Cardiovasc Imaging

Author:

Weissman Neil J.¹,Sanchez Matilde¹,Koch Gary G.¹,Smith Steven R.¹,Shanahan William R.¹,Anderson Christen M.¹

Affiliation:

1. From the MedStar Health Research Institute and Georgetown University, Washington, DC, (N.J.W.); Arena Pharmaceuticals, Inc, San Diego, CA (M.S., W.R.S.); University of North Carolina at Chapel Hill, NC (G.G.K.); Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Medical Research Institute, Orlando, FL (S.R.S.); and Christen M. Anderson Consulting, Encinitas, CA (C.M.A.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Reference30 articles.

1. Serotonergic Drugs

2. Valvular Heart Disease Associated with Fenfluramine–Phentermine

3. Natural History of Valvular Regurgitation 1 Year after Discontinuation of Dexfenfluramine Therapy

4. An Assessment of Heart-Valve Abnormalities in Obese Patients Taking Dexfenfluramine, Sustained-Release Dexfenfluramine, or Placebo

5. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997.;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,1997

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The risk of chronic psychedelic and MDMA microdosing for valvular heart disease;Journal of Psychopharmacology;2023-08-12

2. Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work;Journal of Cardiovascular Development and Disease;2023-07-31

3. 5-HT2C Receptor Stimulation in Obesity Treatment: Orthosteric Agonists vs. Allosteric Modulators;Nutrients;2023-03-17

4. A Critical Review on Obesity: Herbal Approach, Bioactive Compounds, and Their Mechanism;Applied Sciences;2022-08-20

5. Historical and cultural aspects of obesity: From a symbol of wealth and prosperity to the epidemic of the 21st century;Obesity Reviews;2022-03-02